Financhill
Buy
83

ARQT Quote, Financials, Valuation and Earnings

Last price:
$29.44
Seasonality move :
61.76%
Day range:
$29.14 - $29.55
52-week range:
$11.13 - $31.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.83x
P/B ratio:
22.81x
Volume:
1.4M
Avg. volume:
2.3M
1-year change:
96.46%
Market cap:
$3.6B
Revenue:
$196.5M
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for ARQT
Feb 24
2026
Most recent earnings per share
$0.06
Beat by $0.15
(Oct 28/2025)
Consensus Estimate
-$0.09
(Oct 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARQT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 $109.8M -- -- $0.08 --
10/28/2025 Q3 $87M $99.2M $0.06 -$0.09 $0.15
08/06/2025 Q2 $73.7M $81.5M -$0.13 -$0.16 $0.03
05/06/2025 Q1 $62.5M $65.8M -$0.20 -$0.21 $0.01
02/25/2025 Q4 $60.5M $71.4M -$0.09 -$0.26 $0.18
11/06/2024 Q3 $37.3M $44.8M -$0.33 -$0.43 $0.10
08/14/2024 Q2 $29.1M $30.9M -$0.42 -$0.53 $0.11
05/14/2024 Q1 $15.1M $49.6M -$0.32 -$0.73 $0.41
02/27/2024 Q4 $11.4M $13.5M -$0.72 -$0.80 $0.08
11/03/2023 Q3 -- -- -$0.73 -$0.91 $0.18
08/08/2023 Q2 -- -- -$1.16 -$1.25 $0.09
05/09/2023 Q1 -- -- -$1.31 -$1.26 -$0.05
02/28/2023 Q4 -- -- -$1.18 -$1.44 $0.26
11/08/2022 Q3 -- -- -$1.89 -$1.75 -$0.14
08/04/2022 Q2 -- -- -$1.31 -$1.42 $0.11
05/05/2022 Q1 -- -- -$1.27 -- --
02/22/2022 Q4 -- -- -$1.42 -- --
11/04/2021 Q3 -- -- -$1.14 -- --
08/05/2021 Q2 -- -- -$0.84 -- --
05/06/2021 Q1 -- -- -$0.76 -- --
02/16/2021 Q4 -- -- -$0.79 -- --
11/05/2020 Q3 -- -- -$1.01 -- --
08/11/2020 Q2 -- -- -$0.94 -- --
05/12/2020 Q1 -- -- -$1.15 -- --
12/31/2019 Q4 -- -- -$0.36 -- --
09/30/2019 Q3 -- -- -$0.80 -- --
06/30/2019 Q2 -- -- -$0.46 -- --
03/31/2019 Q1 -- -- -$0.37 -- --
12/31/2018 Q4 -- -- -$0.31 -- --

Arcutis Biotherapeutics, Inc. Earnings Questions

  • How Much did Arcutis Biotherapeutics, Inc. Generate in Revenue Last Quarter?

    Arcutis Biotherapeutics, Inc. reported $99.2M worth of top line sales in its most recent quarter.

  • Did Arcutis Biotherapeutics, Inc. Beat Earnings Last Quarter?

    Arcutis Biotherapeutics, Inc. announced earnings per share of $0.06 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Arcutis Biotherapeutics, Inc. Profitable?

    Arcutis Biotherapeutics, Inc. reported $90.5M that represents $0.68 per share over the last quarter.

  • What is the Analyst Consensus for Arcutis Biotherapeutics, Inc. EPS Next Year?

    Arcutis Biotherapeutics, Inc.'s earnings are forecast to decrease from -$1.16 per share to -$1.34 per share next year representing a decrease of -87.04%.

  • When is Arcutis Biotherapeutics, Inc.'s Earnings Date?

    Arcutis Biotherapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
56
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock